Results 201 to 210 of about 59,437 (278)

Clinical Features and Symptom Burden in Vietnamese Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Single-Center Cross-Sectional Study Using IBS-SSS and IBS-QoL Scores. [PDF]

J Clin Med
Nguyen QH, Lam HT, Trinh TTT, Vo TD.
europepmc   +1 more source

Effects of Acupuncture as a Therapeutic Intervention Targeting Both Skin and Gastrointestinal Symptoms in Patients With Atopic Dermatitis: A Randomised Controlled Trial

Clinical &Experimental Allergy, Volume 56, Issue 6, Page 684-688, June 2026.
Jundong Kim, Yerin Seo, Mijung Yeom, Su‐Yang Park, Sujin Lee, Sora Ahn, Dae‐Hyun Hahm, Soon‐Kyeong Kwon, Kyuseok Kim, Hi‐Joon Park   +9 more
wiley   +1 more source

Prevalence and Impact of Disorders of Gut–Brain Interaction in France: Results From the Rome Foundation Global Epidemiology Study

Neurogastroenterology &Motility, Volume 38, Issue 6, June 2026.
Nearly half of adults in France meet Rome IV criteria for disorders of gut–brain interaction, with substantial impairment in quality of life and increased healthcare utilization. Despite this burden, most individuals report no prior medical diagnosis, highlighting persistent challenges in recognition and care.
Tiffany Vo, Tamar Freud, Bruno Bonaz, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami Sperber, Charlotte Desprez, Chloé Melchior   +7 more
wiley   +1 more source

Rethinking Pediatric Dyspepsia: Early Gastric Remodeling as a Unifying Mechanism Behind the Findings of Kim. [PDF]

Pediatr Gastroenterol Hepatol Nutr
La N, Rattanapitoon SK, Arunsan P, Rattanapitoon NK.   +3 more
europepmc   +1 more source

Poliprotect in the PPI Deprescription Phase of Endoscopy‐Negative Heartburn and Epigastric Pain Syndrome Patients: An RCT Post Hoc Analysis

Neurogastroenterology &Motility, Volume 38, Issue 6, June 2026.
Deprescribing PPIs is often difficult because of symptom recurrence and rebound acid hypersecretion, and evidence supporting effective deprescribing strategies is scarce. This post hoc analysis shows that on‐demand Poliprotect is a safe and potentially effective strategy to maintain or improve symptom control in non‐erosive reflux and epigastric pain ...
Enrico Stefano Corazziari, Antonio Gasbarrini, Lucia D'Alba, Valeria D'Ovidio, Oliviero Riggio, Sandro Passaretti, Bruno Annibale, Michele Cicala, Alessandro Repici, Gabrio Bassotti, Carolina Ciacci, Antonio Di Sabatino, Matteo Neri, Maria Consiglia Bragazzi, Emanuela Ribichini, Paola Iovino, Danilo Badiali   +16 more
wiley   +1 more source

Insomnia, A Comorbidity to Take Into Account in the Global Management of Patients With Irritable Bowel Syndrome? [PDF]

Neurogastroenterol Motil
Albert E, Mikhael-Moussa H, Wuestenberghs F, Leroi AM, Netchitailo M, Gourcerol G, Trindade IA, Desprez C, Melchior C.   +8 more
europepmc   +1 more source

Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis. [PDF]

JGH Open
Bandyopadhyay S, Goenka M, Routh D, Ramesh GN, Lawate P.   +4 more
europepmc   +1 more source

Impact of itopride on functional dyspepsia symptom progression: a multicenter noninterventional postregistration study. [PDF]

Ther Adv Gastroenterol
Dolina J, Tack J, Forostyak S, Schol J, Kroupa R, Tachecí I, Bortlík M, Pavlík T, Novotny M.   +8 more
europepmc   +1 more source

Patient-Reported Epigastric Symptom Dynamics During Trimebutine Maleate Treatment: A Post-Marketing Study. [PDF]

Medicina (Kaunas)
Stoev S, Yanachkova V, Petkova-Gueorguieva E, Gueorguiev S, Getova-Kolarova V, Lebanova H, Koynarski V.   +6 more
europepmc   +1 more source

The importance of <i>Helicobacter pylori</i> eradication: a narrative review. [PDF]

Front Gastroenterol (Lausanne)
Casey O, Dobric M, Kelly O, O'Morain CA.
europepmc   +1 more source